Clincosm LogoSign in Get a demo

fuchs endothelial corneal dystrophy

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fuchs Endothelial Corneal Dystrophy Trial (Ripasudil, Placebo)

Not yet recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • (no location specified)
Apr 21, 2023

Fuchs Endothelial Corneal Dystrophy Trial in Kansas City, Portland (Ripasudil, Placebo)

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • Kansas City, Missouri
  • +1 more
Apr 5, 2023

Fuchs Endothelial Corneal Dystrophy Trial in Indianapolis, Houston (STN1010904 ophthalmic suspension 0.03% BID, STN1010904

Recruiting
  • Fuchs Endothelial Corneal Dystrophy
  • STN1010904 ophthalmic suspension 0.03% BID
  • +2 more
  • Indianapolis, Indiana
  • +7 more
Jan 31, 2023

Fuchs Endothelial Corneal Dystrophy, FECD3, Corneal Diseases Trial in London (QR-504a)

Withdrawn
  • Fuchs Endothelial Corneal Dystrophy
  • +4 more
  • London, United Kingdom
    Moorfields Eye Hospital, NIHR Clinical Research Facility
May 5, 2022

Corneal Edema, Corneal Endothelial Dysfunction, Corneal Endothelial Dystrophy Trial in United States (EO2002)

Recruiting
  • Corneal Edema
  • +8 more
  • San Diego, California
  • +5 more
Jan 19, 2022

Fuchs' Corneal Endothelial Dystrophy in France.

Completed
  • Fuchs Endothelial Corneal Dystrophy
  • Collection of datas
  • +2 more
  • Saint-Étienne, France
    Chu Saint-Etienne
Dec 29, 2021

The Postoperative Head Position asPredictor of Surgical Outcome

Unknown status
  • Fuchs Endothelial Corneal Dystrophy
  • +3 more
    • Leipzig, Sachsen, Germany
      Leipzig University Hospital, Department of Ophthalmology
    May 12, 2020